Search

Your search keyword '"Sicurella M"' showing total 22 results

Search Constraints

Start Over You searched for: Author "Sicurella M" Remove constraint Author: "Sicurella M"
22 results on '"Sicurella M"'

Search Results

2. Botulinum Neurotoxin Light Chains Expressed by Defective Herpes Simplex Virus Type-1 Vectors Cleave SNARE Proteins and Inhibit CGRP Release in Rat Sensory Neurons

4. Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery

5. Effects of Flavonoids and Phenols from Moringa oleifera Leaf Extracts on Biofilm Processes in Xanthomonas campestris pv. campestris .

6. Ethosomal Gel for Topical Administration of Dimethyl Fumarate in the Treatment of HSV-1 Infections.

7. Suppressing gain-of-function proteins via CRISPR/Cas9 system in SCA1 cells.

8. The Lesson Learned from the COVID-19 Pandemic: Can an Active Chemical Be Effective, Safe, Harmless-for-Humans and Low-Cost at a Time? Evidence on Aerosolized Hypochlorous Acid.

9. Development and Assessment of Herpes Simplex Virus Type 1 (HSV-1) Amplicon Vectors with Sensory Neuron-Selective Promoters.

10. Control of Erwinia amylovora Growth by Moringa oleifera Leaf Extracts: In Vitro and in Planta Effects.

11. Natural Polyphenol-Containing Gels against HSV-1 Infection: A Comparative Study.

12. Effects of Moringa oleifera Leaf Extracts on Xanthomonas campestris pv. campestris .

13. Mangiferin-Loaded Smart Gels for HSV-1 Treatment.

14. The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation.

15. Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model.

16. Herpes simplex virus type 1 and Alzheimer's disease: link and potential impact on treatment.

17. Botulinum Neurotoxin Light Chains Expressed by Defective Herpes Simplex Virus Type-1 Vectors Cleave SNARE Proteins and Inhibit CGRP Release in Rat Sensory Neurons.

18. Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection.

19. Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide.

20. An attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challenge.

21. The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses.

22. Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells.

Catalog

Books, media, physical & digital resources